4//SEC Filing
VAGELOS P ROY 4
Accession 0001883850-23-000063
CIK 0000872589other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 4:42 PM ET
Size
7.6 KB
Accession
0001883850-23-000063
Insider Transaction Report
Form 4
VAGELOS P ROY
Director
Transactions
- Gift
Common Stock
2023-03-23−25,000→ 312,578 total
Holdings
- 125,752(indirect: by CLAT)
Common Stock
- 3,609(indirect: By Trust)
Common Stock
- 1,963(indirect: By 401(k))
Common Stock
- 23,461(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 21, 2022.
- [F2]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
IncorporatedMD
Related Parties
1- filerCIK 0001013064
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 4:42 PM ET
- Size
- 7.6 KB